| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/14/2007 | US20070134318 Non-tabletted, chewable, individually dosed administration forms |
| 06/14/2007 | US20070134317 Non-effervescent form of sodium naproxen comprising i.a. sodium hydrogen carbonate |
| 06/14/2007 | US20070134316 Soft capsule of butylphthalide and a process for preparing the same |
| 06/14/2007 | US20070134315 Orally administrable extended release pellet and tablet formulations of a highly water soluble compound |
| 06/14/2007 | US20070134314 Therapeutic inhibitor of vascular smooth muscle cells |
| 06/14/2007 | US20070134313 Artificial low-density lipoprotein carriers for transport of substances across the blood-brain barrier |
| 06/14/2007 | US20070134312 Liposomes for treatment of multiple myeloma |
| 06/14/2007 | US20070134311 External preparation |
| 06/14/2007 | US20070134310 Transdermal risperidone delivery system |
| 06/14/2007 | US20070134309 Agent containing ergoline for transdermal application |
| 06/14/2007 | US20070134308 Non-steroidal anti-inflammatory drug formulations for topical applications to the skin |
| 06/14/2007 | US20070134305 Drug-delivering composite structures |
| 06/14/2007 | US20070134304 Soluble article for exfoliating the skin |
| 06/14/2007 | US20070134303 Protective and therapeutic article |
| 06/14/2007 | US20070134302 Antimicrobial substrates with peroxide treatment |
| 06/14/2007 | US20070134301 controlled release antimicrobial wound dressings comprising a substrate having a silver ion releasing chromonic material comprising a chromonic compound and a silver ion source, disposed on the substrate surface |
| 06/14/2007 | US20070134298 Dietary supplement |
| 06/14/2007 | US20070134280 Thixotropic ingestible formulation to treat sore throat |
| 06/14/2007 | US20070134278 Aqueous dispersions and solutions of difficult to dissolve materials and methods of their preparation |
| 06/14/2007 | US20070134277 Pharmaceutical formulation for sulfur-containing drugs in liquid dosage forms |
| 06/14/2007 | US20070134276 Microemulsions of retinoids, and pharmaceutical compositions containing them |
| 06/14/2007 | US20070134268 Vaccines |
| 06/14/2007 | US20070134228 Immunoaffinity purification |
| 06/14/2007 | US20070134212 Engrafting foreign replacement cells within fetal non-human mammal by selectively destroying native cells in tissue of fetal non-human mammal host, wherein number of maternal cells of same tissue is not substantially reduced; thereafter implanting foreign replacement cells in tissue of fetal mammal host |
| 06/14/2007 | US20070134209 Cellular encapsulation for self-assembly of engineered tissue |
| 06/14/2007 | US20070134206 Targeting proteins to deliver therapeutic or diagnostic reagents |
| 06/14/2007 | US20070134200 Immunogenic composition and methods |
| 06/14/2007 | US20070134199 a surface active substance, in particular a non-ionic detergent (tenside), and a mixture of at least two amino acids, are either Glu and Gln or Asp and Asn for stabilization of protein agents in pharmaceuticals |
| 06/14/2007 | US20070134198 Composition and use of RAR antagonists for promoting chondrogenesis |
| 06/14/2007 | US20070134188 Double-stranded RNA oligonucleotides which inhibit tyrosinase expression |
| 06/14/2007 | US20070134175 Reducing adverse reactions of the skin to chemicals e.g. topical cosmetic; side effect reduction |
| 06/14/2007 | US20070134169 Methods for smoking cessation or alcohol cessation or other addiction cessation |
| 06/14/2007 | US20070134168 A coating layer including an antimicrobial agent of a synergistic ratio of Magnolia bark extract and a surfactant of 1:1; bactericides; drug delivery; plaque; antiinflammatory agents; biofilm; breath fresheners; dentistry; chwing gum; candy; soft tablets; dog biscuits; sodium (ammonium) lauryl sulfate |
| 06/14/2007 | US20070134167 Stable foam cream |
| 06/14/2007 | US20070134166 Airway Alkalinization as Therapy for Airway Diseases |
| 06/14/2007 | US20070134165 Use of Ciclesonide for the Treatment of Respiratory Disease in a Smoking Patient |
| 06/14/2007 | US20070134164 Fentanyl composition for nasal administration |
| 06/14/2007 | US20070134154 Tumor-Targeted nanodelivery systems to improve early MRI detection of cancer |
| 06/14/2007 | US20070134153 Lipid-based drug delivery systems against parasitic infections |
| 06/14/2007 | DE102005059751A1 Wässrige Dispersion von superparamagnetischen Eindomänenteilchen, deren Herstellung und Verwendung zur Diagnose und Therapie Aqueous dispersion of superparamagnetic single-domain particles, their preparation and use for the diagnosis and therapy |
| 06/14/2007 | DE102005059606A1 Active agent-application device for application in a gastro-intestinal tract, in a bladder or in uterus, comprises application mechanism with the agent, and a holding mechanism for the application mechanism |
| 06/14/2007 | DE102005058569A1 Schaumwafer mit Polyvinylalkohol-Polyethylenglycol-Pfropfcopolymer Foam wafer with polyvinyl alcohol-polyethylene glycol graft |
| 06/14/2007 | DE10103565B4 Zusammensetzungen, enthaltend einen Ruthenium(III)-komplex und einen Heterocyclus Compositions comprising a ruthenium (III) complex and a heterocycle |
| 06/14/2007 | CA2838111A1 Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof |
| 06/14/2007 | CA2812968A1 Pharmaceutical formulation containing phenytoin sodium and magnesium stearate |
| 06/14/2007 | CA2639696A1 Pharmaceutical compositions comprising cyclosporin |
| 06/14/2007 | CA2633110A1 Transdermal administration of active agents for systemic effect |
| 06/14/2007 | CA2633109A1 Topical pharmaceutical compositions |
| 06/14/2007 | CA2633107A1 Transdermal administration of active agents , in particular diclofenac |
| 06/14/2007 | CA2632798A1 Use of adsorbent carbon microspheres for the treatment of irritable bowel syndrome |
| 06/14/2007 | CA2631872A1 Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof |
| 06/14/2007 | CA2631827A1 Film-coated and/or granulated calcium-containing compounds and use thereof in pharmaceutical compositions |
| 06/14/2007 | CA2631821A1 Pre-compacted calcium-containing compositions |
| 06/14/2007 | CA2631243A1 Liposomal compositions |
| 06/14/2007 | CA2631231A1 Therapeutic agent for corneal/conjuctival disease |
| 06/14/2007 | CA2630595A1 Foam wafer containing a polyvinyl alcohol-polyethyleneglycol-graft copolymer |
| 06/14/2007 | CA2630522A1 Capsules or microcapsules with stable outer hydrophilic layer for rapid buccal disintegration |
| 06/14/2007 | CA2630500A1 Matrix-controlled transdermal system comprising salts of ace inhibitor dicarboxylic acids |
| 06/14/2007 | CA2630458A1 Benzimidazole non-aqueous compositions |
| 06/14/2007 | CA2630261A1 Topical film compositions for delivery of actives |
| 06/14/2007 | CA2629941A1 Lotion-treated tissue and towel |
| 06/14/2007 | CA2629740A1 Zolpidem tablets |
| 06/14/2007 | CA2629599A1 Process for the perparation of lyophilized piperacilline sodium with improved stability after reconstitution |
| 06/14/2007 | CA2624995A1 Orally administrable extended release pellet and tablet formulations of a highly water soluble compound |
| 06/14/2007 | CA2621866A1 Stable solid formulation of sertindole |
| 06/13/2007 | EP1795207A1 Solid pharmaceutical preparation |
| 06/13/2007 | EP1795189A2 Method of administering buprenorphine to treat depression |
| 06/13/2007 | EP1795188A1 Preparation for external use comprising an ionic liquid |
| 06/13/2007 | EP1795187A1 Film forming composition comprising sucralose and carrageenan |
| 06/13/2007 | EP1795186A2 Flupirtin comprising medicament formulation with a controlled release of the active agent |
| 06/13/2007 | EP1795185A2 Nano- and/or micro-particulate formulations for local injection-based treatment of vascular diseases |
| 06/13/2007 | EP1795184A1 Preparation of powders containing colloidal particles |
| 06/13/2007 | EP1795183A1 Aqueous dispersions and solutions of difficult to dissolve compounds and methods of their preparation |
| 06/13/2007 | EP1795182A1 Liposome improving intracellular drug delivery |
| 06/13/2007 | EP1794590A2 Enhanced stability of proteins immobilized on nanoparticles |
| 06/13/2007 | EP1794524A1 Sterile freezing, drying, storing, assaying and filling process (sfd-saf process) (pellet freeze-drying process for parenteral biopharmaceuticals) |
| 06/13/2007 | EP1793872A1 Non-adhesive elastic gelatin matrices |
| 06/13/2007 | EP1793870A2 Odour-reducing quinone compounds |
| 06/13/2007 | EP1793860A1 Composition and method for medical imaging of body cavities |
| 06/13/2007 | EP1793839A2 Fibrous minerals, methods for their production using a solution-precursor-solid mechanism, and methods of use |
| 06/13/2007 | EP1793833A1 Multiple sclerosis treatment |
| 06/13/2007 | EP1793824A1 New pharmaceutical compositions comprising 4-(4-(3-(4-chloro-3-trifluoromethyl-phenyl)-ureido)-3-fluoro-phenoxy)-pyridine-2-carboxylic acid for the treatment of hyper-proliferative disorders |
| 06/13/2007 | EP1793810A1 Nanoparticles and method for the production thereof |
| 06/13/2007 | EP1793809A2 Modified release ibuprofen dosage form |
| 06/13/2007 | EP1793808A1 Solid unit dosage forms of 5-ht1 agonist |
| 06/13/2007 | EP1793806A2 Pharmaceutical formulations containing vitamin e tpgs molecules that solubilize lipophilic drugs without significant efflux inhibition, and use of such formulations |
| 06/13/2007 | EP1793805A1 Liposomal formulations comprising an amphipathic weak base like tempamine for treatment of neurodegenerative conditions |
| 06/13/2007 | EP1793804A2 Use of liposomal glucocorticoids for treating inflammatory states |
| 06/13/2007 | EP1793803A2 Conveniently implantable sustained release drug compositions |
| 06/13/2007 | EP1793802A1 Controlled and directed local delivery of anti-inflammatory compositions |
| 06/13/2007 | EP1793801A1 Novel granulation process and granulate produced therefrom |
| 06/13/2007 | EP1793764A2 Growth factor encapsulation system for enhancing bone formation |
| 06/13/2007 | EP1793690A1 Acorus gramineus soland extract for preventing and treating ischemic heart disease and pharmaceutical composition and health food containing the same |
| 06/13/2007 | EP1793673A1 Cyclodextrin inclusion complexes and methods of preparing same |
| 06/13/2007 | EP1487840B1 Crystalline polymorphic form of irinotecan hydrochloride |
| 06/13/2007 | EP1455810B1 Pharmaceutical formulation comprising cyclosporin and use thereof |
| 06/13/2007 | EP1448456B1 Transdermal/transmucosal patch packaging |
| 06/13/2007 | EP1444247B1 Tibolone formulations |
| 06/13/2007 | EP1438024B1 Process for dispersing a fluid in solid particles |
| 06/13/2007 | EP1387844B1 Retinol derivatives potentiation of active substances by micellar preparation |